Promise and Reality of Biomarkers with John Audette Amplion

Published: July 28, 2016, 4:21 p.m.

John Audette, Co-Founder and President, Amplion talks about how biomarkers are starting to be used by pharmaceutical and diagnostic companies to create more effective drug treatments and tests that use liquid biopsies for early detection of cancer.\xa0

@Amplion

#precisionmedicine

#biomarkers

Amplion